Higher Doses of Radiation Therapy Don’t Increase Survival in Prostate Cancer Patients, Phase 3 Trial Finds

Higher Doses of Radiation Therapy Don’t Increase Survival in Prostate Cancer Patients, Phase 3 Trial Finds
While higher doses of radiation therapy in patients with intermediate-risk prostate cancer lower the need for secondary therapies, the approach does not improve overall survival, results from a Phase 3 clinical trial show. The study, “Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer,” was published in JAMA Oncology. Optimizing radiation therapy for treatment of patients with localized
Subscribe or to access all post and page content.